David Berk, MD
Arcutis Biotherapeutics, Inc.
17
0
16
N/A
0
2
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+8 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (17)
Showing 10 of 17 trials
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Robert Bissonnette, MD
Innovaderm Research Inc.
Shared therapeutic areas:
Robert Bissonnette, MD
Innovaderm Research
Shared therapeutic areas:
Ronald W Gottschalk, MD
Galderma R&D
Shared therapeutic areas:
jianzhong zhang
Peking University People's Hospital
Shared therapeutic areas:
Xinghua Gao
First Hospital of China Medical University
Shared therapeutic areas:
Peter Wolf, MD
Medical University of Graz
Shared therapeutic areas:
Guoqiang Zhang
The First Hospital of Hebei Medical University
Shared therapeutic areas:
Michael Graeber, MD
Galderma R&D
Shared therapeutic areas:
Mark Lebwohl, MD
Icahn School of Medicine at Mount Sinai
Shared therapeutic areas:
Amy Paller, MD
Northwestern University
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (17)
Showing 17 of 17 trials
Topical Roflumilast to Treat Scalp and Body Psoriasis (ARRECTOR)
Trial of PDE4 Inhibition With Roflumilast (ARQ-154) Foam 0.3% for the Management of Seborrheic Dermatitis (STRATUM)
Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis (Integument-PED)
Safety and Efficacy of ARQ-252 Cream 0.3% in Subjects With Non-Segmental Facial Vitiligo
Maximal Usage Pharmacokinetics and Safety of ARQ-151 in Children With Plaque Psoriasis (ARQ-151-216)
Open Label Extension Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis
Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis (INTEGUMENT-II)
Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis
Maximal Usage Pharmacokinetics and Safety of ARQ-151 in Children With Plaque Psoriasis (ARQ-151-215)
Safety and Efficacy of ARQ-252 Cream in Subjects With Chronic Hand Eczema
Maximal Usage Pharmacokinetics and Safety of ARQ-151 in Adolescents and Adults With Chronic Plaque Psoriasis
Open-Label Extension Trial of PDE4 Inhibition With Roflumilast for the Management of Plaque Psoriasis
Pharmacokinetics (PK), Safety, Efficacy and Maximal Use PK of ARQ-151 in Adolescents/Children With Mild/Moderate Eczema
Twin Trial of PDE4 Inhibition With Roflumilast for the Management of Plaque Psoriasis
Safety and Efficacy of ARQ-154 Foam in Subjects With Seborrheic Dermatitis
Safety and Efficacy of ARQ-151 Cream in Adolescents and Adults With Atopic Dermatitis
The Safety, Efficacy and Pharmacokinetics of ARQ-151 Cream in Subjects With Chronic Plaque Psoriasis
All 17 trials loaded